Clinical Trials
3 trialsNCT02125344 2017-07-13
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
GBG Forschungs GmbH
Phase 3 Completed
NCT01426880 2016-02-15
GeparSixto
GBG Forschungs GmbH
Phase 2/3 Completed
NCT00002967 2013-06-21
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed